Deep Medicine Acquisition Corp.
Deep Medicine Acquisition Corp. (DMAQ) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · DMAQ · as of Dec 31, 2024
Ownership Breakdown
15
Institutional Holders
▲ 2 vs Q3
$167,509
Total Inst. Value
▼ $91,807 vs Q3
4.36M
Shares Outstanding
freeFloat 11.52%
250,511
13F Shares Held
▼ 23,369 vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
DMAQ largest shareholders · institutional ownership
Q4 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
YAKIRA CAPITAL MANAGEMENT, INC. blank checks | 47.4K | 1.09% | 1.09% | $31.81M | Feb 13, 2025 | — held |
GEODE CAPITAL MANAGEMENT, LLC blank checks | 42.7K | 98.09% | 98.09% | $28.70M | Feb 12, 2025 | ▼ 1.0K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP blank checks | 25.5K | 58.47% | 58.47% | $17.11M | Feb 14, 2025 | NEW |
UBS GROUP AG blank checks | 22.0K | 50.53% | 50.53% | $14.78M | Feb 14, 2025 | ▲ 14.5K |
RENAISSANCE TECHNOLOGIES LLC blank checks | 17.7K | 40.58% | 40.58% | $11.87M | Feb 13, 2025 | NEW |
CUBIST SYSTEMATIC STRATEGIES, LLC blank checks | 14.9K | 34.11% | 34.11% | $9.98M | Feb 14, 2025 | NEW |
TRAYNOR CAPITAL MANAGEMENT, INC. blank checks | 13.0K | 29.83% | 29.83% | $8.73M | Jan 17, 2025 | ▼ 250 |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. blank checks | 10.3K | 23.67% | 23.67% | $7.00M | Feb 14, 2025 | NEW |
ROYAL BANK OF CANADA blank checks | 5.0K | 11.47% | 11.47% | $3.00M | Feb 14, 2025 | NEW |
TOWER RESEARCH CAPITAL LLC (TRC) blank checks | 1.3K | 2.95% | 2.95% | $863,000 | Feb 13, 2025 | ▼ 4.0K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2024 vs prior quarter
Q4 2024
2
Increased
+14.5K shares6
New Positions
first time holders4
Decreased
−5.3K shares2
Sold Out
fully exitedNet shares change (top 50)
+9.2K
+14.5K / −5.3K
Net new holders
+2
6 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
DMAQ insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Bright Vision Sponsor LLC 10 percent owner | Oct 31, 2023 | J-Other | 150,000 | — | — | 2.87M | Form 4 ↗ |
Bright Vision Sponsor LLC 10 percent owner | Oct 29, 2021 | J-Other | 406,500 | $10.00 | $4.07M | 406.5K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Deep Medicine Acquisition Corp. (DMAQ) is primarily owned by institutional investors, who hold approximately 5.8% of total shares outstanding. Company insiders own approximately 88.48%, while retail and public investors account for the remaining 5.77%.
The largest institutional shareholder of Deep Medicine Acquisition Corp. is YAKIRA CAPITAL MANAGEMENT, INC., holding approximately 47,379 shares — equal to 1.09% of outstanding shares — as of December 31, 2024.
A total of 15 institutional investors currently hold DMAQ stock, with a combined institutional value of approximately $167,509 as of the most recent 13F filing period.
Frequently asked questions
DMAQ ownershipDeep Medicine Acquisition Corp. (DMAQ) is primarily owned by institutional investors, who hold approximately 5.8% of shares. The largest shareholder is YAKIRA CAPITAL MANAGEMENT, INC. with a 1.09% stake. Company insiders hold 88.48%. Data sourced from SEC Form 13F as of December 31, 2024.